Metabolic flux analyses revealed that Mito-BEZ suppresses OXPHOS in cancer cells (Figure 4A), but dramatically upregulates oxidative metabolism and spare respiratory capacity (SRC) in CD8+ T cells as defined by their ability to increase OXPHOS above baseline (Figure 4B). Here, CD8A is linked to cancer.